عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

People Flock to Saudi Arabia's First Int'l Tea Exhibition

People flock to Saudi Arabia's first tea exhibition. (Asharq Al-Awsat)
People flock to Saudi Arabia's first tea exhibition. (Asharq Al-Awsat)
TT
TT

People Flock to Saudi Arabia's First Int'l Tea Exhibition

People flock to Saudi Arabia's first tea exhibition. (Asharq Al-Awsat)
People flock to Saudi Arabia's first tea exhibition. (Asharq Al-Awsat)

Tea is one of the most consumed drinks globally after water, and it is one of the essential traditional drinks in many countries, including Saudi Arabia.

Saudis consider tea a part of their long-standing heritage after it was introduced into the Kingdom nearly a hundred years ago.

Alongside Saudi coffee, tea is a staple at all social occasions.

Saudis’ love for tea was reflected in the tremendous public turnout at the International Tea Colors, which coincides with International Tea Day.

The event was the first hosted by Saudi Arabia that celebrated tea and its baked goods.

The organizers were keen to ensure there were adequate spaces within the halls of the Riyadh International Fair to display the brands and tea products to the public.

Several events will be held on the sidelines of the exhibition, including a tasting and evaluation platform competing for the best dish of sweet and savory snacks accompanying tea.

Shivanka, a Sri Lankan who is an avid tea drinker, specializes in experimenting with tea crops of all kinds and determining their quality.

He said he has been working in this profession for nearly 20 years.

He drinks about 800 cups of tea a day to get used to its taste and distinguish between the different types to determine the best quality.

Shivanka has been working in Saudi Arabia with a company specializing in tea for nearly 15 years. He indicated that Saudis have a distinct palate in tea, so he works hard to ensure that his evaluation is accurate to provide the best possible quality.

Hamad al-Enzi stated that he has enjoyed drinking tea daily for nearly 30 years.

Enzi, touring the exhibition, said that he drinks tea daily and wanted to attend the show and learn more about tea and its types and production details.

He also wanted to learn about the different companies in Saudi Arabia that produce tea.

According to World Bank, Saudis consume eight billion cups of tea annually, and the per capita consumption of tea in the Kingdom in 2020 ranked first in the Arab world with 1.2 kilograms, exceeding consumption per capita globally by 0.2 kilograms.

Most Viewed

 
 
Varieties

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”